Making New Drugs With a Dose of Artificial Intelligence - The New York Times
Your bookmark folders are private.
No folders match. Try another name or add a new folder.
Researchers at DeepMind, owned by Google’s parent company, and other companies are applying their powerful A.I. systems to drug discovery research.
Placed in
Keep exploring
More to explore from shared collections and topics.
Contribute to BackpackerU Resources
Sign in to suggest resources and start organizing your own travel-learning library.
BackpackerU Resources uses cookies from Google to deliver and enhance its services and to analyze traffic.